Hemp Oil–PEA Formulation for ECS-Supported Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing therapies for inflammatory and neuropathic pain often introduce serious complexities and there is a need for methods to enhance the endocannabinoid system (ECS) to treat these conditions without drugs or medical procedures, leveraging naturally occurring cannabinoids like PEA and phytocannabinoids in hemp oil for synergistic effects.
Innovation Solution
A composition comprising palmitoylethanolamide (PEA) and hemp oil is formulated to synergistically support the ECS, reducing inflammation and pain by increasing endocannabinoid levels and enhancing their therapeutic potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If synthetic modulators of ECS are used to treat pain and inflammation, then therapeutic effects are achieved, but serious unexpected complexities and adverse effects are introduced
Solution Approach 1:
The patent replaces complex synthetic ECS modulators with simple, naturally occurring compounds (PEA and phytocannabinoids from hemp) that are metabolized and eliminated naturally by the body. These natural compounds provide therapeutic effects without the serious adverse effects associated with synthetic drugs, allowing repeated use without accumulation of harmful effects.
Solution Approach 2:
The invention leverages the body's own endocannabinoid system and natural metabolic pathways to achieve therapeutic effects. PEA and phytocannabinoids work synergistically with endogenous ECS components, utilizing the body's existing regulatory mechanisms rather than imposing external synthetic control, thereby reducing adverse effects while maintaining reliability.
2Reliability
If PEA and hemp oil are combined to support ECS function, then synergistic therapeutic effects are achieved, but formulation complexity increases
Solution Approach 1:
The patent combines PEA (an endocannabinoid-like molecule) with phytocannabinoids from hemp oil to create a synergistic formulation. This merging of naturally occurring compounds with complementary mechanisms of action enhances therapeutic effects on the ECS while maintaining relative formulation simplicity, as both components are lipophilic and can be delivered together in oil-based vehicles.
Solution Approach 2:
The invention creates a composite formulation combining multiple natural cannabinoids (including CBD, CBG, and other minor cannabinoids present in hemp) with PEA. This composite approach leverages the entourage effect where multiple compounds work together synergistically, providing enhanced therapeutic effects while using naturally derived materials that are metabolized by the body's existing pathways.
Data Source
AI summary
This disclosure provides a composition comprising a synergistic mixture of hemp oil extract and palmitoylethanolamide (PEA), and a method for suppressing inflammatory and neuropathic pain by administering the composition to a subject. The anti-inflammatory and antinociceptive properties of the composition may be attributed by the entourage effect on the endocannabinoid system. Increasing the levels of endocannabinoids by inhibiting either their degradation or transport from the extracellular space back into the cells is a potential therapeutic target for managing these diseases.